Michael Halank - Wissenschaftliche Veröffentlichungen

(1 - 11 von 13

)

International Journal of Cardiology | Vol 272, Suppl, Pages (1...

www.sciencedirect.com

Hanno H. Leuchte, Henrik ten Freyhaus, Henning Gall, Michael Halank, ... Ralf Ewert ... Marius M. Hoeper, Christian Apitz, Ekkehard Grünig, Michael Halank, .

Peer Review reports - BMC Pulmonary Medicinebmcpulmmed.biomedcentral.com › articles › peer-re...

bmcpulmmed.biomedcentral.com

6 Mar 2011, Reviewed, Reviewer Report - Michael Halank. Resubmission - Version 3. Submitted, Manuscript version Sep 2011, Author responded ...

Acute effects of riociguat in borderline or manifest ...

suche.thulb.uni-jena.de

Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease / Hossein A. Ghofrani, Gerd Staehler, Ekkehard Grünig, Michael Halank, Veselin Mitrovic, Sigrun Unger, Wolfgang Mueck, Reiner Frey, Friedrich Grimminger, Ralph T. Schermuly, Juergen Behr

Riociguat treatment in patients with chronic thromboembolic pulmonary...

www.sciencedirect.com

Dr Michael Halank reports personal fees and non-financial support from Actelion, AstraZeneca, Bayer AG, Berlin-Chemie, GSK, OMT, MSD, and Novartis.

Fingolimod in a patient with heart failure on the background of...

bmcneurol.biomedcentral.com

Fingolimod is the first oral immunomodulatory therapy approved for highly active relapsing remitting multiple sclerosis. Based on the distribution pattern of...

Quality of life 3 and 12 months following acute pulmonary ...

suche.thulb.uni-jena.de

Quality of life 3 and 12 months following acute pulmonary embolism : analysis from a prospective multicenter cohort study / Luca Valerio, Stefano Barco, Marius Jankowski, Stephan Rosenkranz, Mareike Lankeit, Matthias Held, Felix Gerhardt, Leonhard Bruch, Ralf Ewert, Martin Faehling, Julia Freise, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, Michael Halank, Marius M. Hoeper, …

Riociguat treatment in patients with pulmonary arterial hypertension:...

www.sciencedirect.com

Dr Michael Halank reports personal fees and non-financial support from Actelion, AstraZeneca, Bayer AG, Berlin-Chemie, GSK, OMT, MSD, and Novartis. Dr George ...

Exercise training in pulmonary arterial hypertension associated with...

arthritis-research.biomedcentral.com

... Gerd Staehler,; Frank Reichenberger,; Henning Tiede,; Michael Halank,; Hans-Jürgen Seyfarth,; Simone Wagner† and; Christian Nagel†.

COSMED France - Cardiopulmonary exercise testing for detecting...

www.cosmed.com

Title: "Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis" - Authors: Daniel Dumitrescu, Christian Nage, Gabor Kovacs, Tom Bollmann, Michael Halank, Jörg Winkler, Martin Hellmich, Ekkehard Grünig, Horst Olschewski, Ralf Ewert, Stephan Rosenkranz - Published in: Heart ...

Pulmonary Hypertension in Patients With COPD: Results From the ...science.rsu.lv › publications › fingerprints

science.rsu.lv

... Roberto Badagliacca, Martin Claussen, Michael Halank, Anton Vonk-Noordegraaf, Dirk Skowasch, Ralf Ewert, J. Simon R. Gibbs, Marion Delcroix Show 7 more

Anxiety and depression disorders in patients with pulmonary arterial...

respiratory-research.biomedcentral.com

... Ardeschir Ghofrani, Stephan Rosenkranz, Hans-Jürgen Seyfarth, Michael Halank, Eckhard Mayer, Ekkehard Grünig* and Stefan Guth.

Verwandte Suchanfragen zu Michael Halank

Carl Gustav Carus
Martin Kolditz
Dirk Skowasch

Gerd Staehler
Stephan Rosenkranz
Hans-Jürgen Seyfarth

Henning Gall
Felix Gerhardt
Hubert Wirtz

Personen
Vorname "Michael" (149265)
Name "Halank" (41)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Wissenschaftliche Veröffentlichungen Michael Halank